NEWHALL CHARLES W III - Insider Non-Derivative Transactions at SUPERNUS PHARMACEUTICALS, INC. (SUPN) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 23, 2024, NEWHALL CHARLES W III's relationship to SUPERNUS PHARMACEUTICALS, INC. (SUPN) is Director, and currently has 120,975 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SUPN insiders.
Data Source: SEC.
NEWHALL CHARLES W III - Insider Non-Derivative Transactions of SUPN Common Stock
NEWHALL CHARLES W III - Insider Non-Derivative Transactions at SUPN
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 24, 2024 | Acquisition -- (Common Stock) | 3886 | 0 | 120975 |
| Nov 17, 2023 | Sell -- (Common Stock) | 2500 | 28.01 | 117089 |
| Nov 17, 2023 | M -- (Common Stock) | 7457 | 9.24 | 119589 |
| Feb 23, 2023 | Acquisition -- (Common Stock) | 3882 | 0 | 112132 |
| Apr 18, 2018 | G -- (Common Stock) | 2203 | 0 | 108250 |